Corticosteroids for high-grade immune checkpoint inhibitor–mediated hepatitis: Is less more?

Jason J. Pan; Nataliya Razumilava

doi:10.1002/hep.32330

Corticosteroids for high-grade immune checkpoint inhibitor–mediated hepatitis: Is less more?

Jason J. Pan, Nataliya Razumilava

Division of Gastroenterology

Research output: Contribution to journal › Editorial

1 Scopus citations

Original language	English
Pages (from-to)	508-510
Number of pages	3
Journal	Hepatology
Volume	75
Issue number	3
DOIs	https://doi.org/10.1002/hep.32330
State	Published - Mar 2022

Access to Document

10.1002/hep.32330

Cite this

@article{9866dfef9c5e493893fdd3b86a145ff6,

title = "Corticosteroids for high-grade immune checkpoint inhibitor–mediated hepatitis: Is less more?",

author = "Pan, {Jason J.} and Nataliya Razumilava",

note = "Funding Information: Supported by NIH K08‐DK122114‐01 and Gilead Sciences Research Scholar awards to N.R. ",

year = "2022",

month = mar,

doi = "10.1002/hep.32330",

language = "English",

volume = "75",

pages = "508--510",

journal = "Hepatology",

issn = "0270-9139",

number = "3",

}

TY - JOUR

T1 - Corticosteroids for high-grade immune checkpoint inhibitor–mediated hepatitis

T2 - Is less more?

AU - Pan, Jason J.

AU - Razumilava, Nataliya

N1 - Funding Information: Supported by NIH K08‐DK122114‐01 and Gilead Sciences Research Scholar awards to N.R.

PY - 2022/3

Y1 - 2022/3

UR - http://www.scopus.com/inward/record.url?scp=85124464545&partnerID=8YFLogxK

U2 - 10.1002/hep.32330

DO - 10.1002/hep.32330

M3 - Editorial

C2 - 35007345

AN - SCOPUS:85124464545

SN - 0270-9139

VL - 75

SP - 508

EP - 510

JO - Hepatology

JF - Hepatology

IS - 3

ER -

Corticosteroids for high-grade immune checkpoint inhibitor–mediated hepatitis: Is less more?

Access to Document

Other files and links

Cite this